Less Ads, More Data, More Tools Register for FREE

Faron Pharmaceuticals Inks Share Liquidity Pact With Lago Kapital

Fri, 29th Nov 2019 10:23

(Alliance News) - Faron Pharmaceuticals Oy said Friday it has entered into a liquidity providing agreement with Lago Kapital Ltd, a Finnish securities lender and financial services provider.

Under the agreement, Lago will quote bids and offers for Faron's shares within the framework of the Nasdaq First North Growth Market Finland rules for liquidity provision.

Nasdaq First North is a division of Nasdaq Nordic and an alternative stock exchange for smaller European companies.

The spread of the bid and offer prices is set at a maximum of 4% calculated on the bid price. The quotes on bid and offer must be at least EUR3,000 worth of shares.

The agreement is subject to the accepted listing of Faron's shares on Nasdaq First North, which is expected to take place on December 3.

The agreement will be in force initially for a fixed term of three months and thereafter until further notice, with a notice period of one calendar month.

Shares in the Turku, Finland-based clinical stage biopharmaceutical company were up 6.1% at 243.95 pence on Friday in London.

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

Related Shares

More News

Faron Pharmaceuticals Alters Traumakine Study After US FDA Feedback

Faron Pharmaceuticals Alters Traumakine Study After US FDA Feedback

6 Feb 20 14:17

Faron Pharma To Test Clevegen In Patients With Ovarian Cancer

Faron Pharma To Test Clevegen In Patients With Ovarian Cancer

27 Jan 20 11:22

Faron Pharma Gets Approval For Part II Trial Of Clevegen Drug

Faron Pharma Gets Approval For Part II Trial Of Clevegen Drug

13 Jan 20 11:54

Faron Pharma requests arbitration over Traumakine manufacturing deal

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced on Monday that, further to the update on 'Traumakine' drug substance manufacturing on 2 October, it has carried out a detailed investigation into the circumstances around manufacturing arrangements.

30 Dec 19 15:39

Login to your account

Don't have an account? Click here to register.